|本期目录/Table of Contents|

[1]金佳佳,吕镗烽综述,宋勇审校.间充质干细胞治疗ARDS作用机制的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2017,19(06):615-619.[doi:10.3969/j.issn.1672-271X.2017.06.014]
点击复制

间充质干细胞治疗ARDS作用机制的研究进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第19卷
期数:
2017年06期
页码:
615-619
栏目:
综述
出版日期:
2017-11-23

文章信息/Info

Title:
-
作者:
金佳佳; 吕镗烽综述; 宋勇审校
作者单位： 210002南京，南京军区南京总医院呼吸内科
Author(s):
-
关键词:
间充质干细胞; 治疗; 作用机制; 旁分泌
Keywords:
-
分类号:
R641
DOI:
10.3969/j.issn.1672-271X.2017.06.014
文献标志码:
A
摘要:
间充质干细胞（mesenchymal stromal/stem cells, MSCs）在急性呼吸窘迫综合征（acute respiratory distress syndrome, ARDS）中有着潜在的治疗作用，现在认为主要的机制在于MSCs通过旁分泌可溶性生物活性因子与受损组织相互作用。文章着重介绍MSCs如何通过旁分泌作用减轻ARDS肺损伤严重程度及增强肺组织修复，同时对MSCs在ARDS疾病治疗的最新研究进行综述。
Abstract:
-

参考文献/References:

[1]耿申, 吴婷, 穆先敏, 等. 细胞间粘附分子-1在ARDS小鼠肺微血管内皮细胞内的表达变化[J]. 医学研究生学报, 2016, 29(4): 342-347.
[2]Matthay MA. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome[J]. Ann Am Thorac Soc, 2015, 12(Suppl 1): S54-57.
[3]Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing[J]. Stem Cells, 2007, 25(11): 2739-2749.
[4]韩钦, 李康华, 何东南, 等. 肾缺血-再灌注损伤模型中Flk-1+间质干细胞参与损伤修复的机制研究[J]. 医学研究生学报, 2008, 21(6): 599-603.
[5]Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues[J]. Proc Natl Acad Sci USA, 2003, 100(Suppl 1)： 11917-11923.
[6]Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells[J]. Stem Cells, 2007, 25(11): 2886-2895.
[7]Mirabella T, Poggi A, Scaranari M, et al. Recruitment of host’s progenitor cells to sites of human amniotic fluid stem cells implantation[J]. Biomaterials, 2011, 32(18): 4218-4227.
[8]Hua J, Gong J, Meng H, et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow[J]. Cell Biol Int, 2014, 38(2): 198-210.
[9]Heldman AW, Difede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial[J]. Jama, 2014, 311(1): 62-73.
[10]Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD[J]. Chest, 2013, 143(6): 1590-1598.
[11]Hu SL, Luo HS, Li JT, et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells[J]. Crit Care Med, 2010, 38(11): 2181-2189.
[12]Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study[J]. Lancet, 2008, 371(9624): 1579-1586.
[13]Curley GF, Ansari B, Hayes M, et al. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury[J]. Anesthesiology, 2013, 118(4): 924-932.
[14]Walter J, Ware LB, Matthay MA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis[J]. Lancet Respir Med, 2014, 2(12): 1016-1026.
[15]Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury[J]. Proc Natl Acad Sci USA, 2007, 104(26): 11002-11007.
[16]Danchuk S, Ylostalo JH, Hossain F, et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6[J]. Stem Cell Res Ther, 2011, 2(3): 1-15.
[17]Zhou J, Jiang L, Long X, et al. Bone-marrow-derived mesenchymal stem cells inhibit gastric aspiration lung injury and inflammation in rats[J]. J Cell Mol Med, 2016, 20(9): 1706-1717.
[18]Zhu H, Xiong Y, Xia Y, et al. Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury Mice[J]. Sci Rep, 2017, 7: 39889.
[19]Wagner W, Roderburg C, Wein F, et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors[J]. Stem Cells, 2007, 25(10): 2638-2647.
[20]Dittrich A, Hessenkemper W, Schaper F. Systems biology of IL-6, IL-12 family cytokines[J]. Cytokine Growth Factor Rev, 2015, 26(5): 595-602.
[21]Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective[J]. Annu Rev Immunol, 2009, 27(1): 451-483.
[22]Lee JW, Krasnodembskaya A, Mckenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria[J]. Am J Respir Crit Care Med, 2013, 187(7): 751-760.
[23]Bhattacharya J, Matthay MA. Regulation and repair of the alveolar-capillary barrier in acute lung injury[J]. Annu Rev Physiol, 2013, 75(1): 593-615.
[24]Fang X, Neyrinck AP, Matthay MA, et al. Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1[J]. J Biol Chem, 2010, 285(34): 26211-26222.
[25]Goolaerts A, Pellanrandrianarison N, Larghero J, et al. Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury[J]. Am J Physiol Lung Cell Mol Physiol, 2014, 306(11): 975-985.
[26]Pati S, Gerber MH, Menge TD, et al. Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock[J]. PLoS One, 2011, 6(9): e25171.
[27]Yang Y, Chen QH, Liu AR, et al. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway[J]. Stem Cell Res Ther, 2015, 6(1): 250.
[28]Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2001, 163(6): 1376-1383.
[29]Chan MC, Kuok DI, Leung CY, et al. Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo[J]. Proc Natl Acad Sci USA, 2016, 113(13): 3621-3626.
[30]Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung[J]. Proc Natl Acad Sci USA, 2009, 106(38): 16357-16362.
[31]Jackson MV, Morrison TJ, Doherty DF, et al. Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS[J]. Stem Cells, 2016, 34(8): 2210-2223.
[32]Krasnodembskaya A, Song Y, Fang X, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37[J]. Stem Cells, 2010, 28(12): 2229-2238.
[33]Gupta N, Krasnodembskaya A, Kapetanaki M, et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia[J]. Thorax, 2012, 67(6): 533-539.
[34]Mendez-Samperio P. Recent advances in the field of antimicrobial peptides in inflammatory diseases[J]. Adv Biomed Res, 2013, 2(2): 50.
[35]Sung DK, Chang YS, Sung SI, et al. Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta- defensin- 2 via toll- like receptor 4 signalling[J]. Cell Microbiol, 2016, 18(3): 424-436.
[36]Herold S, Gabrielli NM, Vadasz I. Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 305(10): L665-681.
[37]Raffaghello L, Bianchi G, Bertolotto M, et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche[J]. Stem Cells, 2008, 26(1): 151-162.
[38]Ottonello L, Frumento G, Arduino N, et al. Differential regulation of spontaneous and immune complex-induced neutrophil apoptosis by proinflammatory cytokines. Role of oxidants, Bax and caspase-3[J]. J Leukoc Biol, 2002, 72(1): 125-132.
[39]Asensi V, Valle E, Meana A, et al. In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis[J]. Infect Immun, 2004, 72(7): 3823-3828.
[40]Xiang B, Chen L, Wang X, et al. Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury[J]. Int J Mol Sci, 2017, 18(4).
[41]Xu Y, Xiang J, Zhao H, et al. Human amniotic fluid stem cells labeled with up-conversion nanoparticles for imaging-monitored repairing of acute lung injury[J]. Biomaterials, 2016, 100: 91-100.
[42]Zhu YG, Feng XM, Abbott J, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice[J]. Stem Cells, 2014, 32(1): 116-125.
[43]Monsel A, Zhu YG, Gennai S, et al. Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice[J]. Am J Respir Crit Care Med, 2015, 192(3): 324-336.
[44]Pedrazza L, Cunha AA, Luft C, et al. Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation[J]. J Cell Physiol, 2017, 232(12): 3552-3564.
[45]Bianco P, Cao X, Frenette PS, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine[J]. Nat Med, 2013, 19(1): 35-42.
[46]Weiss DJ, Bertoncello I, Borok Z, et al. Stem cells and cell therapies in lung biology and lung diseases[J]. Proc Am Thorac Soc, 2011, 8(3): 223-272.
[47]Zheng G, Huang L, Tong H, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study[J]. Respir Res, 2014, 15(1): 39.
[48]Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial[J]. Lancet Respir Med, 2015, 3(1): 24-32.
[49]Simonson OE, Mougiakakos D, Heldring N, et al. In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome[J]. Stem Cells Transl Med, 2015, 4(10): 1199-1213.

相似文献/References:

[1]邓云,丁惠,居颂光,等.复发性自然流产的病因及治疗现状[J].医学研究与战创伤救治(原医学研究生学报),2013,15(02):167.
[2]李向阳,樊 荣,丁友宏,等.十二指肠营养管外套胃肠引流管在胃瘫患者中的应用[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):461.[doi:10.3969/j.issn.1672-271X.2013.05.010]
　LI Xiang-yang,FAN Rong,DING You-hong,et al.Application of duodenal nutrition tube jacket gastrointestinal drainage tube in treatment for gastric paralysis after esophagectomy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):461.[doi:10.3969/j.issn.1672-271X.2013.05.010]
[3]张智斌,阙镇如,冉 骞,等.低温等离子刀与传统手术治疗会厌囊肿的比较分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):515.[doi:10.3969/j.issn.1672-271X.2013.05.028]
[4]李 鹏,孙星慧,蒋晓明.睾丸胚胎性横纹肌肉瘤1例并文献复习[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):517.[doi:10.3969/j.issn.1672-271X.2013.05.029]
[5]王峻峰,沈旭峰,袁 挺,等.驻某地军人急腹症的临床分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):68.
[6]徐 健,赵秋良,张维维.成功救治危重症哮喘致呼吸心搏骤停1例[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):63.
[7]杨林东,周秋明,李 娜.原发性输卵管移行细胞癌1例[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):128.
[8]梁菁菁,蒋 戚,邹大进.羟氯喹治疗2型糖尿病[J].医学研究与战创伤救治(原医学研究生学报),2012,14(03):267.
[9]齐玉琴,张兴虎,万文辉,等.中老年人多原发癌32例分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):402.
　QI Yu-qin,ZHANG Xing-hu,WAN Wen-hui,et al.Analysis of 32 cases multiple primary carcinomas in the aged[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(06):402.
[10]傅 点综述,薛 松审校.感染性结石的成因及治疗现状[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):446.

备注/Memo

备注/Memo:
基金项目： 国家自然科学基金(81570078)
更新日期/Last Update: 2017-11-20